TG Therapeutics, Inc (TGTX) insider trading

Every open-market stock purchase and sale by TG Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Laurence N Charney (Director) sold $275K in the last 90 days.
  • Last insider buy: Michael S Weiss (CEO), $1M, 3 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $438K (2 sales). Last close $53.16 on Oct 22, 2026.

Recent TGTX insider trades

DateInsiderTradeValue
Sep 10, 2026Laurence N Charney (Director)Sold$275K
Aug 7, 2026Laurence N Charney (Director)Sold (not open market)—
Aug 7, 2026Laurence N Charney (Director)Sold (not open market)—
Aug 6, 2026Laurence N Charney (Director)Sold (not open market)—
Jun 11, 2026Laurence N Charney (Director)Bought (not open market)—
Jun 11, 2026Yann Echelard (Director)Bought (not open market)—
Jun 11, 2026Daniel Hume (Director)Bought (not open market)—
Jun 11, 2026Kenneth Hoberman (Director)Bought (not open market)—
Jun 11, 2026Sagar Lonial (Director)Bought (not open market)—
Jan 29, 2026Laurence N Charney (Director)Sold (not open market)—
Jan 28, 2026Laurence N Charney (Director)Sold (not open market)—
Jan 8, 2026Sean A Power (CFO)Bought (not open market)—
Jan 8, 2026Michael S Weiss (CEO)Bought (not open market)—
Nov 24, 2025Yann Echelard (Director)Sold$163K
Nov 5, 2025Michael S Weiss (CEO)Sold (not open market)—
Nov 5, 2025Michael S Weiss (CEO)Sold (not open market)—

Who's trading TGTX

Get free alerts when an insider at TG Therapeutics, Inc files a new trade →